These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 23157781)
1. Poor efficacy of oral tacrolimus in the treatment of severe generalized atopic eczema in adults: a small retrospective case series. Lee FJ; Frankum BS; Katelaris CH Australas J Dermatol; 2012 Nov; 53(4):295-7. PubMed ID: 23157781 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial. Wolff K; Fleming C; Hanifin J; Papp K; Reitamo S; Rustin M; Shear N; Silny W; Korman N; Marks I; Cherill R; Emady-Azar S; Paul C; Br J Dermatol; 2005 Jun; 152(6):1296-303. PubMed ID: 15948996 [TBL] [Abstract][Full Text] [Related]
3. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study. Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819 [TBL] [Abstract][Full Text] [Related]
4. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227 [TBL] [Abstract][Full Text] [Related]
5. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C; Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994 [TBL] [Abstract][Full Text] [Related]
6. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975 [TBL] [Abstract][Full Text] [Related]
7. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Zoller L; Ramon M; Bergman R Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134 [TBL] [Abstract][Full Text] [Related]
8. Topical [symbol: see text] tacrolimus--a role in atopic dermatitis? Drug Ther Bull; 2002 Oct; 40(10):73-5. PubMed ID: 12434738 [TBL] [Abstract][Full Text] [Related]
9. Atopic dermatitis management with tacrolimus ointment (Protopic). Kapp A; Allen BR; Reitamo S J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634 [TBL] [Abstract][Full Text] [Related]
10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL; Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204 [TBL] [Abstract][Full Text] [Related]
11. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis. Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179 [TBL] [Abstract][Full Text] [Related]
12. Tacrolimus ointment: new preparation. Too many unknowns. Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141 [TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study. Reitamo S; Ortonne JP; Sand C; Bos J; Cambazard F; Bieber T; Grønhøj-Larsen C; Rustin M; Fölster-Holst R; Schuttelaar M; Acta Derm Venereol; 2007; 87(5):406-12. PubMed ID: 17721647 [TBL] [Abstract][Full Text] [Related]
14. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K; Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017 [TBL] [Abstract][Full Text] [Related]
15. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis]. de Bruin-Weller MS; Bruijnzeel-Koomen CA Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135 [TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. Hanifin JM; Paller AS; Eichenfield L; Clark RA; Korman N; Weinstein G; Caro I; Jaracz E; Rico MJ; J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S186-94. PubMed ID: 16021174 [TBL] [Abstract][Full Text] [Related]
18. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. Naylor M; Elmets C; Jaracz E; Rico JM J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180 [TBL] [Abstract][Full Text] [Related]
19. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis. Keaney TC; Bhutani T; Sivanesan P; Bandow GD; Weinstein SB; Cheung LC; Malick F; Koo J J Am Acad Dermatol; 2012 Oct; 67(4):636-41. PubMed ID: 22221776 [TBL] [Abstract][Full Text] [Related]
20. The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. Patel RR; Vander Straten MR; Korman NJ Arch Dermatol; 2003 Sep; 139(9):1184-6. PubMed ID: 12975161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]